• 充值
  • 会员
  • 职称材料
搜期刊
刊名

文献信息

  • 任意字段
  • 主题词
  • 篇关摘
  • 篇名
  • 关键词
  • 摘要
  • 作者
  • 第一作者
  • 作者单位
  • 刊名
  • 中图分类号
  • 学科分类号
  • DOI
  • 基金

Infectious Diseases and Therapy 中科院2区 JCR:Q1 SCIE PubMed
发文量 1,406
被引量 26,920
影响因子(2025版) 4.357

Infectious Diseases and Therapy is an international, open access, peer-reviewed (single-blind), and rapid publication journal. The scope of the journal is broad, dedicated to the publication of high-quality clinical, observational, real-world, and health outcomes research around the discovery, development, and use of therapeutics and interventions, including devices, across all areas of infectious diseases. The key features of the journal are: Rapid publication: The journal aims for a 2-week peer review, 3-4 weeks from acceptance to online. Open access: All articles published open access (CC BY-NC). Inclusivity: All scientifically sound research considered be it positive, confirmatory or negative data. Research is considered from clinical phase, real-world and health economics outcomes studies. Submissions are welcomed whether they relate to an international or a country-specific audience. Personal service: The journal’s team will re-format articles and upload submissions on behalf of authors, if necessary. Digital Features and Plain Language Summaries: These peer-reviewed features are welcomed to help enhance the educational value of a manuscript (for more information see “Author Information – Guidelines for digital features and plain language summaries” under “Submission guidelines”). Publication fees: Upon acceptance of an article, authors will be required to pay the mandatory Rapid Service Fee of €5500/$6850/£4700. The journal will consider fee discounts and waivers for developing countries and this is decided on a case by case basis. If you would like to request a discount or waiver please do so either ahead of submission or at the very start of the submission process. Requests made after this stage will not be considered. Contact: For more information about the journal, including pre-submission enquiries, please contact Hannah Payne at hannah.payne@springer.com. Publishing research on infectious disease therapies and interventions Rapid publication and personal point of contact throughout Maximum visibility with open access

  • 主办单位: SPRINGER LONDON LTD
  • 出版地区: LONDON
  • 出版周期: 季刊
  • 别名: INFECT DIS THER;Infect. Dis. Ther.;Infectious Diseases & Therapy;传染病和治疗;INFECTIOUS DISEASES AND THERAPY
  • 国际标准连续出版物号/电子版 ISSN 2193-8229 / EISSN 2193-6382
  • 创刊时间: 2012年
收录汇总 栏目浏览 期刊详情
收录汇总
出版文献
期刊详情
新发布(2025版)
分析评价

期刊信息

  • 主办单位:SPRINGER LONDON LTD
  • 主  编:Michael J. Rybak,Alex Soriano
  • 地  址: LONDON

期刊简介

Infectious Diseases and Therapy is an international, open access, peer-reviewed (single-blind), and rapid publication journal. The scope of the journal is broad, dedicated to the publication of high-quality clinical, observational, real-world, and health outcomes research around the discovery, development, and use of therapeutics and interventions, including devices, across all areas of infectious diseases. The key features of the journal are: Rapid publication: The journal aims for a 2-week peer review, 3-4 weeks from acceptance to online. Open access: All articles published open access (CC BY-NC). Inclusivity: All scientifically sound research considered be it positive, confirmatory or negative data. Research is considered from clinical phase, real-world and health economics outcomes studies. Submissions are welcomed whether they relate to an international or a country-specific audience. Personal service: The journal’s team will re-format articles and upload submissions on behalf of authors, if necessary. Digital Features and Plain Language Summaries: These peer-reviewed features are welcomed to help enhance the educational value of a manuscript (for more information see “Author Information – Guidelines for digital features and plain language summaries” under “Submission guidelines”). Publication fees: Upon acceptance of an article, authors will be required to pay the mandatory Rapid Service Fee of €5500/$6850/£4700. The journal will consider fee discounts and waivers for developing countries and this is decided on a case by case basis. If you would like to request a discount or waiver please do so either ahead of submission or at the very start of the submission process. Requests made after this stage will not be considered. Contact: For more information about the journal, including pre-submission enquiries, please contact Hannah Payne at hannah.payne@springer.com. Publishing research on infectious disease therapies and interventions Rapid publication and personal point of contact throughout Maximum visibility with open access